lobbying_activities: 988140

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
988140	b5f81920-cd21-4c29-a761-a1927fc1c75a	Q3	CHAMBER HILL STRATEGIES	400645947	BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.	2010	third_quarter	MMM	Implementation issues affecting biopharmaceutical manufacturers related to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act of 2010	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2010-10-06T12:12:48.830000-04:00